“Depending on who you talk to, artificial intelligence (AI) is either a saviour or an enslaver. The concerns range from loss of jobs through to robots running society. However, in the life sciences, the use of AI and machine learning (ML) have created some excitement over their potential applications.”
Our CEO Liesbeth Ceelen shares her expertise in an article recently published in European Biotechnology.
Read the whole article here.
AI has quickly become part of everyday biotech research, helping scientists navigate information, write code and make sense of complex data. But chat-based tools have their limits. They can provide answers and guidance, but they cannot always do the actual scientific work. As biotech moves beyond the chatbox, the next step is putting AI to work directly within research workflows.
BioLizard is proud to have received the Best Poster Award at the European Society for Spatial Biology (ESSB) conference, recognising our work on benchmarking cell segmentation methods for single-cell spatial transcriptomics.
KMOinsider and Netwerkers.be, host a panel of four perspectives on leadership, with discussions spanning strategy, communication, trust, autonomy and the role of people in organisational growth.
